M.J. Pierik
Recent publications
-
Bak, M. T. J., Demers, K., van Ruler, O., Pierik, M. J., van Dijk, D. P. J., van der Bilt, J. D. W., Romberg-Camps, M., Dijkstra, G., Duijvestein, M., van der Marel, S., Maljaars, P. W. J., Buskens, C. J., Bakers, F. C. H., Brecheisen, R., Bongers, B. C., de Witte, D., Jansen, S. V., Jharap, B., Horjus, C. S., ... Dutch Initiative on Crohn and Colitis – Surgery (ICC-S) (2026). Preoperative body composition parameters are associated with postoperative outcomes in patients with Crohn's disease. Clinical gastroenterology and hepatology, 24(5), 1413-1423. https://doi.org/10.1016/j.cgh.2025.06.039More information about this publication
-
Verleye, L. M. M., Pierik, M. J., de Vries, A. C., van Schaik, F. D. M., van der Meulen-de Jong, A. E., van Dop, W. A., Lowenberg, M., Visschedijk, M. C., Naber, M. R., Bouwknegt, D. G., Romkens, T. E. H., Bodelier, A. G. L., Voorneveld, P. W., Oldenburg, B., Derikx, L. A. A. P., Duijvestein, M., Mujagic, Z., & Dutch Initiative Crohn and Colitis (2026). Prospective real-world experience with risankizumab in difficult-to-treat Crohn's disease: results from the Dutch Initiative on Crohn and Colitis Registry. Inflammatory Bowel Diseases. Advance online publication. https://doi.org/10.1093/ibd/izag045More information about this publication
-
Okegunna, Y., Sekar, M., Adriaans, G. M. C., Cloots, M. J. J., Zhang, J., Aliu, A., Hendrix, E. M. B., Romberg-Camps, M., Rezazadeh Ardabili, A., Mujagic, Z., Dekker, A., Pierik, M. J., & Fijten, R. R. R. (2026). Advancing Predictive Modeling of Inflammatory Bowel Disease (IBD) Flares: A Data-Driven Approach Using Lifestyle and Psychosocial Factors from a Remote Monitoring Platform. Digestive Diseases and Sciences. Advance online publication. https://doi.org/10.1007/s10620-026-09750-8More information about this publication
-
van Renterghem, A. R. P. K. M., van der Holst, A. M., van Kuijk, S., Belgers, E. H. J., Romberg-Camps, M., Pierik, M., & Stassen, L. P. S. (2026). Recurrence After Ileocolic Resection for Crohn's Disease: Further Unraveling the Search for Risk Factors. Diseases of the Colon & Rectum, 69(2), 191-200. https://doi.org/10.1097/DCR.0000000000004014More information about this publication
-
Naber, M. R., van der Meulen, A. E., Voorneveld, P. W., Veltkamp, S. H. C., van Bodegraven, A. A., Bodelier, A., Mujagic, Z., Pierik, M., Verleye, L. M. M., Duijvestein, M., Bouwknegt, D. G., Visschedijk, M. C., Srivastava, N., West, R. L., Oldenburg, B., Lowenberg, M., van Schaik, F. D. M., & Dutch ICC Registry (2026). Filgotinib Is an Effective and Safe Treatment Option for Difficult-To-Treat Ulcerative Colitis: Real-World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry. United European Gastroenterology Journal, 14(1), Article e70141. https://doi.org/10.1002/ueg2.70141More information about this publication
-
Versteegh, M., Idema, D. L., Huygens, S., Jenniskens, K., Pierik, M., Römkens, T., van Schaik, F., Wahab, P., Huis in't Veld, L. F., Kusters, M., van der Braak, K., Hooft, L., & Damen, J. A. A. (2026). Comparative Efficacy of all Available Pharmaceutical Therapies for Moderate to Severe Crohn's Disease: A Systematic Review and Network Meta-Analysis. Gastro Hep Advances, 5(1), Article 100764. https://doi.org/10.1016/j.gastha.2025.100764More information about this publication
-
Naber, M., Bouwknegt, D. G., Visschedijk, M., Lourens, L., Van der Meulen-de Jong, A. E., Bodelier, A., Duijvestein, M., Van Bodegraven, A. A., De Vries, A. C., Mujagic, Z., Pierik, M., Verleye, L., West, R., Romkens, T., Jharap, B., van der Marel, S., van der Voorn, M., Mensink, P., Mares, W., ... Dutch Initiative on Crohn and Colitis (ICC) Registry (2026). Effectiveness of JAK inhibitors in JAK naïve Ulcerative Colitis patients: Comparative analysis of tofacitinib, filgotinib and upadacitinib in the Dutch ICC Registry. Journal of Crohn's & Colitis, 20, Article jjaf2311262. https://doi.org/10.1093/ecco-jcc/jjaf231.1262More information about this publication
-
De Klaver, P. A. G., Van Woerkens, A. M. H., D'agnolo, H. M. A., Pierik, M. J., & Derijks, L. J. J. (2025). Retrospective Validation of Clinical Decision Support Tools for Predicting Effectiveness Outcomes in Inflammatory Bowel Disease Patients Treated with Vedolizumab. Pharmaceutics, 18(1), Article 15. https://doi.org/10.3390/pharmaceutics18010015More information about this publication
-
Demers, K., van den Bergh, N., Bongers, B. C., van Kuijk, S. M. J., Mujagic, Z., Jonkers, D. M. A. E., Pierik, M. J., & Stassen, L. P. S. (2025). Health-Related Physical Fitness in Patients With Inflammatory Bowel Disease vs Healthy Control Subjects. Inflammatory Bowel Diseases, 31(12), 3337-3355. Article izaf169. https://doi.org/10.1093/ibd/izaf169More information about this publication
-
Versteegh, M. M., Huygens, S. A., Bermejo, I., Grimm, S., Pierik, M., Romkens, T., van Schaik, F., & Wahab, P. (2025). Cost-Utility Analysis of Treatment Sequences for Moderate-to-Severe Crohn's Disease. Pharmacoeconomics, 43(12), 1405-1417. https://doi.org/10.1007/s40273-025-01531-xMore information about this publication